UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 414

Sortiert nach

Genomic Landscape of Endometrial, Ovarian, and Cervical Cancers in Japan from the Database in the Center for Cancer Genomics and Advanced Therapeutics

Cancers, 2023-12, Vol.16 (1), p.136

2023

Link zum Volltext

Verfügbarkeit prüfen

Histone arginine methyltransferase CARM1 selective inhibitor TP-064 induces apoptosis in endometrial cancer

Biochemical and biophysical research communications, 2022-04, Vol.601, p.123-128

2022

Link zum Volltext

Verfügbarkeit prüfen

The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway

BMC cancer, 2018-12, Vol.18 (1), p.1201-1201, Article 1201

2018

Link zum Volltext

Verfügbarkeit prüfen

Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma

Gynecologic oncology, 2019-11, Vol.155 (2), p.331-339

2019

Link zum Volltext

Verfügbarkeit prüfen

Suspicious Positive Peritoneal Cytology (Class III) in Endometrial Cancer Does Not Affect Prognosis

Journal of clinical medicine, 2022-11, Vol.11 (21), p.6527

2022

Link zum Volltext

Verfügbarkeit prüfen

Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma

Journal for immunotherapy of cancer, 2020-05, Vol.8 (1), p.e000375

2020

Link zum Volltext

Verfügbarkeit prüfen

The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma

Oncoimmunology, 2017-08, Vol.6 (8), p.e1338996-e1338996

2017

Link zum Volltext

Verfügbarkeit prüfen

Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy

Archives of gynecology and obstetrics, 2023-11, Vol.308 (5), p.1629-1634

2023

Link zum Volltext

Verfügbarkeit prüfen

Risk stratification of invasive cervical cancer diagnosed after cervical conization

Japanese journal of clinical oncology, 2023-12, Vol.53 (12), p.1138-1143

2023

Link zum Volltext

Verfügbarkeit prüfen

A case of refractory pelvic squamous cell carcinoma of unknown primary that responded to nivolumab

The journal of obstetrics and gynaecology research, 2023-04, Vol.49 (4), p.1300-1304

2023

Link zum Volltext

Verfügbarkeit prüfen

Heterogeneous effects of cytotoxic chemotherapies for platinum-resistant ovarian cancer

International journal of clinical oncology, 2023-09, Vol.28 (9), p.1207-1217

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5721: Neoantigen load and HLA-class I expression characterize a subset of HR-proficient high-grade serous ovarian carcinomas with favorable prognosis and T cell-inflamed phenotype

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5721-5721

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of pelvic radiotherapy on patients with stage IB‑IIA cervical cancer after radical hysterectomy: A single‑center retrospective study

Oncology letters, 2023-03, Vol.25 (3), p.1, Article 112

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical and pathological examination of 11 cases of ovarian seromucinous tumor at our institute

European journal of gynaecological oncology, 2022-06, Vol.43 (3), p.127

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1706: Neoantigen frequency as an independent prognostic factor in patients with clear cell ovarian carcinoma (CCOC)

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1706-1706

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 969A: The histone methyltransferase EZH2 is a novel target of anticancer therapy in endometrial cancer

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.969-969A

2016

Link zum Volltext

Verfügbarkeit prüfen

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53

Oncotarget, 2016-11, Vol.7 (46), p.75328-75338

2016

Link zum Volltext

Verfügbarkeit prüfen

Temperature Dependence of the Resistance of AlGaN/GaN Heterostructures and Their Applications as Temperature Sensors

Japanese Journal of Applied Physics, 2010-04, Vol.49 (4), p.04DF14-04DF14-4

2010

Link zum Volltext

Verfügbarkeit prüfen

Recent Zinc Refining Operation at Hikoshima Smelting Co.,Ltd

Journal of MMIJ, 2007-01, Vol.123 (12), p.657-660

2007

Link zum Volltext

Verfügbarkeit prüfen

Recent Operation at Hikoshima Smelter

Journal of MMIJ, 2010-01, Vol.126 (6), p.279-282

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical Relevance of BRCA1/2 Pathogenic Variants and Impaired DNA Repair Pathways in Ovarian Carcinomas

Personalization in Gynecologic Oncology, 2022, p.59-76

Mandai, Masaki

2022

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and characterization of deoxycholyl 2‐deoxyglucuronide: A water‐soluble affinity labeling reagent

Lipids, 2003-08, Vol.38 (8), p.873-n/a

2003

Link zum Volltext

Verfügbarkeit prüfen

A Case of Giant Cystoma of Ovary

Journal of Nippon Medical School, 1953, Vol.20(3), pp.301-308

Nishijima, Akira

1953

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 414

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(285)
Mit Volltextzugriff
(394)

Publikationsform

Sprache

Englisch
(350)
Japanisch
(173)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Genomic Landscape of Endometrial, Ovarian, and Cervical Cancers in Japan from the Database in the Center for Cancer Genomics and Advanced Therapeutics

Histone arginine methyltransferase CARM1 selective inhibitor TP-064 induces apoptosis in endometrial cancer

The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway

Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma

Suspicious Positive Peritoneal Cytology (Class III) in Endometrial Cancer Does Not Affect Prognosis

Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma

The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma

Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy

Risk stratification of invasive cervical cancer diagnosed after cervical conization

A case of refractory pelvic squamous cell carcinoma of unknown primary that responded to nivolumab

Heterogeneous effects of cytotoxic chemotherapies for platinum-resistant ovarian cancer

A novel clinically applicable biomarker for testing HRD status based on the mutational signatures: Results for the phase 2 trial of olaparib maintenance monotherapy in patients with primary high-grade ovarian carcinoma (2271)

Inhibition of protein arginine methyltransferase 6 activates interferon signaling and induces the apoptosis of endometrial cancer cells via histone modification

Abstract 5721: Neoantigen load and HLA-class I expression characterize a subset of HR-proficient high-grade serous ovarian carcinomas with favorable prognosis and T cell-inflamed phenotype

Effect of pelvic radiotherapy on patients with stage IB‑IIA cervical cancer after radical hysterectomy: A single‑center retrospective study

Clinical and pathological examination of 11 cases of ovarian seromucinous tumor at our institute

Abstract 1706: Neoantigen frequency as an independent prognostic factor in patients with clear cell ovarian carcinoma (CCOC)

Abstract 969A: The histone methyltransferase EZH2 is a novel target of anticancer therapy in endometrial cancer

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53

Temperature Dependence of the Resistance of AlGaN/GaN Heterostructures and Their Applications as Temperature Sensors

Recent Zinc Refining Operation at Hikoshima Smelting Co.,Ltd

Recent Operation at Hikoshima Smelter

Clinical Relevance of BRCA1/2 Pathogenic Variants and Impaired DNA Repair Pathways in Ovarian Carcinomas

Synthesis and characterization of deoxycholyl 2‐deoxyglucuronide: A water‐soluble affinity labeling reagent

A Case of Giant Cystoma of Ovary

Suchergebnisse filtern